Welcome to the Linkedin page of UMR1011, headed by Prof. Bart Staels. UMR1011 studies the biological mechanisms controlling the development and progression of type 2 diabetes, metabolic dysfunction-associated liver disease (MASLD) and their cardiovascular complications, with the aim of developing preventive and therapeutic strategies.
UMR1011 is supervised by the University of Lille, INSERM, the Lille University Hospital and the Pasteur Institute of Lille.
Company Details
- Employees
- 10
- Founded
- 2010
- Address
- 1, Rue Du Professeur Calmette, Lille,hauts-De-France 59800,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://u1011.univ-lille.fr/
- Keywords
- Polaris.
- HQ
- Lille, Hauts-de-France
Nuclear Receptors, Metabolic And Cardiovascular Diseases (Pr Bart Staels) Questions
Nuclear Receptors, Metabolic And Cardiovascular Diseases (Pr Bart Staels)'s website is https://u1011.univ-lille.fr/
Nuclear Receptors, Metabolic And Cardiovascular Diseases (Pr Bart Staels)'s LinkedIn profile is https://fr.linkedin.com/company/umr1011-pr-bart-staels
Nuclear Receptors, Metabolic And Cardiovascular Diseases (Pr Bart Staels) has
10 employees.
View email and phone details for 10
employees at Nuclear Receptors, Metabolic And Cardiovascular Diseases (Pr Bart Staels).
Nuclear Receptors, Metabolic And Cardiovascular Diseases (Pr Bart Staels)'s industry is
Biotechnology Research
Nuclear Receptors, Metabolic And Cardiovascular Diseases (Pr Bart Staels)'s top competitors are
Institut Pasteur,
Institut Imagine,
Phd Inov,
Gustave Roussy,
Institut Pasteur De Lille,
Abolis Biotechnologies,
France Biotech,
Research Labs @ Supbiotech,
Polaris,
Sth Biotech.
Nuclear Receptors, Metabolic And Cardiovascular Diseases (Pr Bart Staels)'s categories are Biotechnology Research
Nuclear Receptors, Metabolic And Cardiovascular Diseases (Pr Bart Staels)'s founding year is 2010
